Chuhan Z.

Chuhan Z. is a seasoned professional in the healthcare investment sector, currently serving at Qatar Investment Authority since March 2023, focusing on biotechnologies and pharmaceuticals. Prior to this role, Chuhan Z. held the position of Senior Investment Manager at Platanus (Wu Capital) from January 2019 to February 2023, concentrating on early-stage biotech and pharmaceutical investments alongside VC/PE fund investments, with notable deals including Medbanks, Belief BioMed, SciWind Biosciences, and Ranok Therapeutics. Chuhan Z. previously worked as a Senior Scientist at Merck in 2018, specializing in formulation development for antibodies and related biologics, and completed a research fellowship at Mayo Clinic from 2010 to 2011, where animal models for PIPK1-gamma pathway targets were established. Academically, Chuhan Z. earned a Doctor of Philosophy (PhD) in Chemistry from Princeton University and a Bachelor of Science (BS), summa cum laude, in Chemistry and Biochemistry from the University of Minnesota Duluth.